Clinical Trials Directory

Trials / Unknown

UnknownNCT03219944

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation Around Implant in the Aesthetic Zone: A Randomized Control Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Conditions

Interventions

TypeNameDescription
PROCEDUREPlatelet Rich Fibrin: Platelet Rich Fibrin for soft tissue augmentation around implant in the aesthetic zone
PROCEDUREsub epithelial connective tissue graftsub epithelial connective tissue graft for soft tissue augmentation around implant in the aesthetic zone

Timeline

Start date
2017-08-15
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2017-07-18
Last updated
2017-07-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03219944. Inclusion in this directory is not an endorsement.